Cell line generation (CLG) in the scope of bioproduction can be defined as a method to isolate a single cell expressing a recombinant protein of interest.
According to our (Global Info Research) latest study, the global Cell Line Generation market size was valued at US$ 1855 million in 2023 and is forecast to a readjusted size of USD 3525 million by 2030 with a CAGR of 9.7% during review period.
Global key players of cell line generation include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 39%. In terms of product, knockout cell lines are the largest segment, with a share over 49%. And in terms of application, the largest application is pharmaceutical industry, with a share over 70%.
This report is a detailed and comprehensive analysis for global Cell Line Generation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Cell Line Generation market size and forecasts, in consumption value ($ Million), 2019-2030
Global Cell Line Generation market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Cell Line Generation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Cell Line Generation market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Line Generation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Line Generation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, Sartorius, Merck, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Porton Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell Line Generation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Cell Line Generation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Knockout Cell Lines
Overexpression Cell Lines
Inducible Expression Cell Lines
Knockdown Cell Lines
Knockin Cell Lines
Others
Market segment by Application
Pharmaceutical Industry
Biological Industry
Market segment by players, this report covers
Boehringer Ingelheim BioXcellence
Lonza
WuXi Biologics
Thermo Fisher Scientific
Sartorius
Merck
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Porton Biologics
Chempartner Pharmatech
Rentschler Biopharma
ProBioGen
AGC Biologics
OPM Biosciences
Charles River Laboratories
Mycenax Biotech
JOINN Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Line Generation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Line Generation, with revenue, gross margin, and global market share of Cell Line Generation from 2019 to 2024.
Chapter 3, the Cell Line Generation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell Line Generation market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Line Generation.
Chapter 13, to describe Cell Line Generation research findings and conclusion.
Summary:
Get latest Market Research Reports on Cell Line Generation. Industry analysis & Market Report on Cell Line Generation is a syndicated market report, published as Global Cell Line Generation Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cell Line Generation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.